Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed May 15, 2026 · 10-Q · 45 days after period end · 0001493152-26-023538
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$2.07M | -$1.35M | -$800.33K | -$785.08K |
| EPS Diluted | -$0.02 | -$0.02 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
